glp 1 medication over the counter cvs to cover Zepbound again, expanding access to GLP-1 drug CVS obesity drug deal puts

Last reviewed: June 29, 2026 Last updated: June 29, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

The bone receptors may affect bone formation and turnover

Phase 3 trials for obesity and weight-related conditions are enrolling patients

Some patients report feeling unusually cold during their first weeks of treatment, a symptom tied directly to decreased caloric intake and changes in thermogenic (heat-producing) pathways

Fabi is also an assistant clinical professor at the University of California, San Diego

Albumin is a rough read on protein and nutritional status, and keeping it in range is one signal that you are eating enough protein to protect lean mass